Fidelity Investments’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Buy |
|
|||||
|
2025
Q1 | $112K | Sell |
|
|||||
|
2024
Q4 | $294K | Sell |
|
|||||
|
2024
Q3 | $859K | Buy |
|
|||||
|
2024
Q2 | $1.2M | Buy |
|
|||||
|
2024
Q1 | $886K | Buy |
|
|||||
|
2023
Q4 | $543K | Buy |
|
|||||
|
2023
Q3 | $289K | Buy |
|
|||||
|
2023
Q2 | $320K | Buy |
|
|||||
|
2023
Q1 | $207K | Buy |
|
|||||
|
2022
Q4 | $340K | Sell |
|
|||||
|
2022
Q3 | $601K | Buy |
|
|||||
|
2022
Q2 | $391K | Buy |
|
|||||
|
2022
Q1 | $771K | Buy |
|
|||||
|
2021
Q4 | $1.16M | Sell |
|
|||||
|
2021
Q3 | $6.85M | Buy |
|
|||||
|
2021
Q2 | $9.79M | Sell |
|
|||||
|
2021
Q1 | $16.6M | Sell |
|
|||||
|
2020
Q4 | $23.1M | Sell |
|
|||||
|
2020
Q3 | $16.7M | Sell |
|
|||||
|
2020
Q2 | $28.2M | Sell |
|
|||||
|
2020
Q1 | $29.6M | Sell |
|
|||||
|
2019
Q4 | $155M | Sell |
|
|||||
|
2019
Q3 | $157M | Buy |
|
|||||
|
2019
Q2 | $150M | Sell |
|
|||||
|
2019
Q1 | $207M | Buy |
|
|||||
|
2018
Q4 | $208M | Sell |
|
|||||
|
2018
Q3 | $304M | Sell |
|
|||||
|
2018
Q2 | $439M | Buy |
|
|||||
|
2018
Q1 | $292M | Buy |
|
|||||
|
2017
Q4 | $174M | Buy |
|
|||||
|
2017
Q3 | $131M | Buy |
|
|||||
|
2017
Q2 | $111M | Buy |
|
|||||
|
2017
Q1 | $120M | Buy |
|
|||||
|
2016
Q4 | $76.9M | Buy |
|
|||||
|
2016
Q3 | $101M | Buy |
|
|||||
|
2016
Q2 | $99.2M | Buy |
|
|||||
|
2016
Q1 | $103M | Buy |
|
|||||
|
2015
Q4 | $144M | Buy |
|
|||||
|
2015
Q3 | $131M | Buy |
|
|||||
|
2015
Q2 | $55.1M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $5.62M | Sell |
|
|||||
|
2014
Q1 | $6.79M | Buy |
|